Peer-reviewed article
MBRS-14. INTEGRATING CLINICAL AND GENOMIC CHARACTERISTICS IN PEDIATRIC MEDULLOBLASTOMA SUBTYPES IN A SINGLE COHORT IN TAIWAN
Wu K, Wong T ·
Summary
Written by AI, not yet AICS's view · claude-haiku-4-5-20251001This is a medical research study on medulloblastoma, a type of brain cancer in children. The researchers analyzed genetic and clinical characteristics of 52 childhood cases in Taiwan to classify them into molecular subtypes. The study identifies different survival rates and metastasis patterns across subtypes but does not evaluate an intervention for child well-being.
Key points
- 52 childhood medulloblastomas were classified into 11 subtypes using molecular profiling
- WNT subtype tumors showed 100% survival rate with no metastasis
- G3 gamma subtype showed the highest metastatic rate and worst survival associated with MYC amplification
- Different subtypes present at different ages (infants vs children)
- Monosomy 6 was present in WNT alpha but not beta subtype
Limitations
This is a descriptive molecular classification study of a single cohort with no intervention tested. It cannot tell us about the effectiveness of any treatment approach or what impacts child well-being outcomes beyond survival rates.
Abstract
Abstract BACKGROUND Medulloblastoma (MB) was classified to 4 molecular subgroups: WNT, SHH, group 3 (G3), and group 4 (G4) with the demographic and clinical differences. In 2017, The heterogeneity within MB was proposed, and 12 subtypes with distinct molecular and clinical characteristics. PATIENTS AND METHODS: PATIENTS AND METHODS We retrieved 52 MBs in children to perform RNA-Seq and DNA methylation array. Subtype cluster analysis performed by similarity network fusion (SNF) method. With clinical results and molecular profiles, the characteristics including age, gender, histological variants, tumor location, metastasis status, survival, cytogenetic and genetic aberrations among MB subtypes were identified. RESULTS In this cohort series, 52 childhood MBs were classified into 11 subtypes by SNF cluster analysis. WNT tumors shown no metastasis and 100% survival rate. All WNT tumors located on midline in 4th ventricle. Monosomy 6 presented in WNT α, but not in β subtype. SHH α and β occurred in children, while SHH γ in infant. Among SHH tumors, α subtype showed the worst outcome. G3 γ showed the highest metastatic rate and worst survival associated with MYC amplification. G4 α has the highest metastatic rate, however G4 γ showed the worst survival. CONCLUSION We identified molecular subgroups and subtypes of MBs based on gene expression and DNA methylation profile in children in our cohort series. The results may contribute to the establishment of nation-wide correlated optimal diagnosis and treatment strategies for MBs in infant and children.